The Latest Breaking News from Prescription Drug

Moderna Inc (NASDAQ:MRNA) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc (NYSE:PFE) and the Trump administration to lower prescription drug prices.

Under the deal, New York-based Pfizer will charge most-favoured-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations.

Prescription drug costs weigh heavily on retirees’ budgets. Medicare Part D offers relief, but choosing the wrong plan can waste hundreds—or even thousands—each year. The...

Prescription drug costs remain one of the biggest worries for retirees. Medicare Part D was designed to help, but the program is full of choices...

The Trump administration is urging public health agencies to prioritize investigations of vaccine injuries, prescription drug use, and the cause of autism

Billionaire entrepreneur Mark Cuban, in a series of posts on the social media platform X early Monday morning, launched a scathing critique of the U.S. prescription drug industry, accusing large wholesalers and Pharmacy Benefit Managers (PBMs) of creating a “stranglehold” on pricing through opaque, anti-competitive practices.

On Thursday, the U.S. Food and Drug Administration (FDA) extended the Prescription Drug User Fee Act (PDUFA) goal date for Agios Pharmaceuticals, Inc.’s (NASDAQ:AGIO) supplemental New Drug Application (sNDA) of Pyrukynd (mitapivat) for adult patients with non-transfusion-dependent (NTD) and transfusion-dependent (TD) alpha- or beta-thalassemia by three months to December 7, 2025. 

The U.S. Food and Drug Administration (FDA) on Monday extended the Prescription Drug User Fee Act (PDUFA) goal date for Axogen Inc.’s (NASDAQ:AXGN) Biologics License Application (BLA) for Avance Nerve Graft by three months to December 5.

High prescription drug costs are one of the biggest burdens retirees face, but a new option is set to bring relief. If you want to delay Part D prescriptions and spread payments out over time instead of paying them all upfront, a change beginning Jan 1 makes it possible. This…